Clinical Trial Update: Effect of Liraglutide on the Beta-cell Responsiveness in Subjects With Type 2 Diabetes Compared to a Healthy Control Group [Phase 1]

View source ↗

Summary

A Phase 1 study evaluating the effect of liraglutide on beta-cell responsiveness in subjects with Type 2 diabetes mellitus compared with healthy controls; the t…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• liraglutide (liraglutide)

Snippet

Sponsor: Novo Nordisk A/S | Conditions: Diabetes, Diabetes Mellitus, Type 2 | Phase 1 | Status: COMPLETED